Chromadex Sees Black in 1Q10

IRVINE, Cali.ChromaDex Corp. (OTCBB: CDXC) a contract research lab, released financial results for the first quarter of 2010 (1Q10), highlighting a 34-percent increase in revenues to $1.94 million in 1Q10 from $1.45 million in 1Q last year. Net income attributable to common stockholders was $.34 million or less than $0.01 per share for 1Q10, compared to a net loss of $.32 million for the same quarter in 2009. The company attributed the earnings gain in the quarter to the increase in revenues coupled with a decrease in direct labor and overhead as a percentage of sales.

With the launch of pTeroPure and the growth of our core business, we are in an ideal position to be the partner of choice for food, beverage, dietary supplement, and cosmetic companies as they look to strengthen their respective businesses through new product offerings and improved product quality, said Frank Jaksch, CEO and co-founder of ChromaDex.